Joe G. Greener

Joe G. Greener

Auto-generated profile, based on publicly available information

Joe G. Greener

Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, UK

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2021 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
JGJoe G. Greener
Joe G. Greener
SKShaun Kandathil
Shaun Kandathil
LMLewis Moffat
Lewis Moffat
DJDavid T. Jones
David T. Jones

4 September 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
JGJoe G. Greener
Joe G. Greener
SKShaun Kandathil
Shaun Kandathil
DJDavid T. Jones
David T. Jones
The inapplicability of amino acid covariation methods to small protein families has limited their use for structural annotation of whole genomes. Recently, deep learning has shown promise in allowing accurate residue-residue contact prediction even for shallow sequence alignments. Here we introduce DMPfold, which uses deep learning to predict inter-atomic distance bounds, the main chain hydrogen bond network, and torsion angles, which it uses to build models in an iterative fashion. DMPfold produces more accurate models than two popular methods for a test set of CASP12 domains, and works just as well for transmembrane proteins. Applied to all Pfam domains without known structures, confident models for 25% of these so-called dark families were produced in under a week on a small 200 core cluster. DMPfold provides models for 16% of human proteome UniProt entries without structures, generates accurate models with fewer than 100 sequences in some cases, and is freely available.

1 November 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JGJoe G. Greener
Joe G. Greener
LMLewis Moffat
Lewis Moffat
DJDavid T Jones
David T Jones
The design of novel proteins has many applications but remains an attritional process with success in isolated cases. Meanwhile, deep learning technologies have exploded in popularity in recent years and are increasingly applicable to biology due to the rise in available data. We attempt to link protein design and deep learning by using variational autoencoders to generate protein sequences conditioned on desired properties. Potential copper and calcium binding sites are added to non-metal binding proteins without human intervention and compared to a hidden Markov model. In another use case, a grammar of protein structures is developed and used to produce sequences for a novel protein topology. One candidate structure is found to be stable by molecular dynamics simulation. The ability of our model to confine the vast search space of protein sequences and to scale easily has the potential to assist in a variety of protein design tasks.

23 October 2015 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
JGJoe G Greener
Joe G Greener
MSMichael Je Sternberg
Michael Je Sternberg
Despite being hugely important in biological processes, allostery is poorly understood and no universal mechanism has been discovered. Allosteric drugs are a largely unexplored prospect with many potential advantages over orthosteric drugs. Computational methods to predict allosteric sites on proteins are needed to aid the discovery of allosteric drugs, as well as to advance our fundamental understanding of allostery.

1 June 2018 in Current Opinion in Structural Biology
Verified
Journal Article
Open access
JGJoe G Greener
Joe G Greener
MSMichael Je Sternberg
Michael Je Sternberg
Allostery is the functional change at one site on a protein caused by a change at a distant site. In order for the benefits of allostery to be taken advantage of, both for basic understanding of proteins and to develop new classes of drugs, the structure-based prediction of allosteric binding sites, modulators and communication pathways is necessary. Here we review the recently emerging field of allosteric prediction, focusing mainly on computational methods. We also describe the search for cryptic binding pockets and attempts to design allostery into proteins. The development and adoption of such methods is essential or the long-preached potential of allostery will remain elusive.

26 March 2018 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
GCGregory B. Craven
Gregory B. Craven
DADominic P. Affron
Dominic P. Affron
CACharlotte E. Allen
Charlotte E. Allen
SMStefan Matthies
Stefan Matthies
JGJoe G. Greener
Joe G. Greener
DMDavid J. Mann
David J. Mann
Cysteine‐reactive small molecules are used as chemical probes of biological systems and as medicines. Identifying high‐quality covalent ligands requires comprehensive kinetic analysis to distinguish selective binders from pan‐reactive compounds. Quantitative irreversible tethering (qIT), a general method for screening cysteine‐reactive small molecules based upon the maximization of kinetic selectivity, is described. This method was applied prospectively to discover covalent fragments that target the clinically important cell cycle regulator Cdk2. Crystal structures of the inhibitor complexes validate the approach and guide further optimization. The power of this technique is highlighted by the identification of a Cdk2‐selective allosteric (type IV) kinase inhibitor whose novel mode‐of‐action could be exploited therapeutically.